Red Cedar Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.52M Sell
20,972
-120
-0.6% -$13.9K 0.26% 60
2025
Q4
$2.22M Hold
21,092
0.24% 60
2025
Q3
$1.77M Hold
21,092
0.21% 61
2025
Q2
$1.67M Hold
21,092
0.21% 60
2025
Q1
$1.89M Sell
21,092
-10,004
-32% -$934K 0.26% 56
2024
Q4
$3.09M Sell
31,096
-7,463
-19% -$769K 0.39% 36
2024
Q3
$4.38M Hold
38,559
0.56% 26
2024
Q2
$4.77M Buy
38,559
+5,798
+18% +$747K 0.65% 22
2024
Q1
$4.32M Buy
32,761
+1,531
+5% +$189K 0.54% 31
2023
Q4
$3.4M Hold
31,230
0.49% 35
2023
Q3
$3.22M Buy
31,230
+1,118
+4% +$121K 0.49% 36
2023
Q2
$3.47M Buy
30,112
+7,367
+32% +$836K 0.53% 29
2023
Q1
$2.42M Buy
22,745
+11,493
+102% +$1.24M 0.37% 41
2022
Q4
$1.25M Buy
+11,252
New +$1.15M 0.2% 48
2021
Q1
Sell
-8,711
Closed -$680K 90
2020
Q4
$680K Hold
8,711
0.1% 68
2020
Q3
$689K Sell
8,711
-4,437
-34% -$348K 0.13% 57
2020
Q2
$970K Buy
+13,148
New +$990K 0.23% 37

Other funds holding MRK

Red Cedar Investment Management's MRK Position: Q1 2026 in Review

Red Cedar Investment Management reduced its Merck (MRK) stake by 0.57% in Q1 2026, selling an estimated $13.9K and leaving 20,972 shares worth $2.52M. The position accounts for 0.26% of the portfolio, ranked #60.

Red Cedar Investment Management first reported a position in MRK in Q2 2020 and has held it in 17 quarters since. The position peaked at $4.77M in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Red Cedar Investment Management held 20,972 shares of Merck worth $2.52M as of Q1 2026.
  • Red Cedar Investment Management sold 120 Merck shares in Q1 2026, an estimated $13.9K.
  • Merck made up 0.26% of Red Cedar Investment Management's portfolio in Q1 2026, its #60 holding.
  • Red Cedar Investment Management first reported a position in Merck in Q2 2020 and has held it in 17 quarters since.
  • Red Cedar Investment Management's Merck position peaked at $4.77M in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Red Cedar Investment Management's 13F filing for Q1 2026, filed 30 Apr 2026.